Gilead Sciences to Present at the Barclays Capital 2010 Global Healthcare Conference on Wednesday, March 24

Webcast Available Through Gilead Corporate Website
FOSTER CITY, Calif., Mar 17, 2010 (BUSINESS WIRE) -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Barclays Capital 2010 Global Healthcare Conference in Miami.

Kevin Young, Gilead's Executive Vice President, Commercial Operations, will provide an overview of the company on Wednesday, March 24 at 10:15 a.m. Eastern Daylight Time.

To access the live webcast via the internet log on to www.gilead.com. Please connect to the company's website at least 15 minutes prior to the live presentation to ensure adequate time for any software download that may be necessary to listen to the webcast.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

For more information on Gilead Sciences, please visit www.gilead.com or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

SOURCE: Gilead Sciences, Inc.

Gilead Sciences, Inc.
Susan Hubbard, 650-522-5715 (Investor Relations)